CDT

Medtronic to announce financial results for its fourth quarter and full fiscal year 2024

Retrieved on: 
Giovedì, Maggio 9, 2024

DUBLIN, May 9, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024.

Key Points: 
  • DUBLIN, May 9, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2024 on Thursday, May 23, 2024.
  • The news release will include summary financial information for the company's fourth quarter and full fiscal year 2024, which ended on Friday, April 26, 2024.
  • Medtronic will host a video webcast at 7:00 a.m. CDT on Thursday, May 23, 2024, to discuss results for its fourth quarter and full fiscal year 2024.
  • Looking ahead, Medtronic plans to report its first, second, third, and fourth quarter fiscal year 2025 results on Tuesday, August 20, 2024, Tuesday, November 19, 2024, Tuesday, February 18, 2025, and Thursday, May 22, 2025, respectively.

DallasNews Corporation Announces Schedule for First Quarter 2024 Financial Results Release and Conference Call

Retrieved on: 
Mercoledì, Maggio 8, 2024

DALLAS, May 08, 2024 (GLOBE NEWSWIRE) -- DallasNews Corporation (Nasdaq: DALN) said today that it will release first quarter 2024 financial results after the market closes on Tuesday, May 14, 2024.

Key Points: 
  • DALLAS, May 08, 2024 (GLOBE NEWSWIRE) -- DallasNews Corporation (Nasdaq: DALN) said today that it will release first quarter 2024 financial results after the market closes on Tuesday, May 14, 2024.
  • A conference call will be held on Thursday, May 16, 2024 at 9:00 a.m. CDT.
  • The conference call will be simultaneously webcast on DallasNews Corporation’s website at investor.dallasnewscorporation.com/events .
  • A replay line will be available at 1-866-207-1041 from 12:00 p.m. CDT on May 16, 2024 until 11:59 p.m. CDT on May 22, 2024.

Know Labs to Present Clinical Research at the 2024 American Association of Clinical Endocrinology Annual Meeting

Retrieved on: 
Giovedì, Maggio 9, 2024

Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been selected for an oral abstract presentation at the American Association of Clinical Endocrinology (AACE) Annual Meeting in New Orleans, Louisiana on May 9, 2024 from 11:15 a.m. – 11:30 a.m. CDT.

Key Points: 
  • Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been selected for an oral abstract presentation at the American Association of Clinical Endocrinology (AACE) Annual Meeting in New Orleans, Louisiana on May 9, 2024 from 11:15 a.m. – 11:30 a.m. CDT.
  • During 2024, as the Company continues on the path toward FDA clearance, Know Labs will deploy the KnowU™, its wearable, non-invasive continuous glucose monitor (CGM) in large-scale, external clinical trials while advancing model techniques and making refinements to the device.
  • These new studies will help determine the technology’s performance throughout continuous wear, in more real-world environments, and within more extreme glycemic ranges (below 70 mg/dL and above 350 mg/dL).
  • To stay updated on the latest results, visit www.knowlabs.co/research-and-development .

Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting

Retrieved on: 
Mercoledì, Maggio 8, 2024

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present information on the preclinical profile of STAR-0310 at the upcoming Society for Investigative Dermatology (SID) Annual Meeting in Dallas, Texas on May 16, 2024.

Key Points: 
  • Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present information on the preclinical profile of STAR-0310 at the upcoming Society for Investigative Dermatology (SID) Annual Meeting in Dallas, Texas on May 16, 2024.
  • Dr. Chunxia Lily Zhao, Director of Antibody Discovery at Astria Therapeutics, will present a poster titled, “Preclinical Profile of STAR-0310, a Novel OX40 Antagonistic Monoclonal Antibody” at Session One of the Pharmacology and Therapeutic Development Select E-Poster Discussions on May 16, 2024, at 5:00pm CDT.

The Toro Company to Announce Fiscal 2024 Second Quarter Results

Retrieved on: 
Mercoledì, Maggio 8, 2024

The Toro Company (NYSE: TTC), a leading global provider of solutions for the outdoor environment, announced today that it will release its fiscal 2024 second quarter results on Thursday, June 6, at approximately 7:30 a.m. CDT.

Key Points: 
  • The Toro Company (NYSE: TTC), a leading global provider of solutions for the outdoor environment, announced today that it will release its fiscal 2024 second quarter results on Thursday, June 6, at approximately 7:30 a.m. CDT.
  • The full text of The Toro Company’s earnings release will be available at that time at www.thetorocompany.com/invest .
  • The company will also hold an earnings conference call at 10 a.m. CDT that day.
  • For those unable to listen to the live webcast, a replay will be available at www.thetorocompany.com/invest .

US Foods Reports First Quarter Fiscal Year 2024 Earnings

Retrieved on: 
Giovedì, Maggio 9, 2024

US Foods Holding Corp. (NYSE: USFD), one of the largest foodservice distributors in the United States, today announced results for the first quarter fiscal year 2024.

Key Points: 
  • US Foods Holding Corp. (NYSE: USFD), one of the largest foodservice distributors in the United States, today announced results for the first quarter fiscal year 2024.
  • The ratio of Net Debt to Adjusted EBITDA was 2.8x at the end of the first quarter of fiscal 2024, compared to 2.8x at the end of fiscal 2023 and 3.2x at the end of the first quarter of fiscal 2023.
  • During the first quarter of fiscal 2024, the Company repurchased 0.3 million shares of common stock at an aggregate purchase price of $13 million.
  • US Foods will host a live webcast to discuss first quarter fiscal 2024 results on Thursday, May 9, 2024, at 8 a.m. CDT.

UL Solutions Inc. Sets Date for First Quarter 2024 Results

Retrieved on: 
Mercoledì, Maggio 8, 2024

UL Solutions Inc. (NYSE: ULS), a global safety science leader in independent third-party testing, inspection and certification services and related software and advisory offerings, today announced it will release financial results for the first quarter 2024 before the market opens on Monday, May 20, 2024.

Key Points: 
  • UL Solutions Inc. (NYSE: ULS), a global safety science leader in independent third-party testing, inspection and certification services and related software and advisory offerings, today announced it will release financial results for the first quarter 2024 before the market opens on Monday, May 20, 2024.
  • Management will host a webcast and conference call that same day at 8:30 a.m. EDT (7:30 a.m. CDT) to review results.
  • To listen to the call and view the slides, please visit the Investor Relations section of UL Solutions’ website at www.ul.com .
  • For those who are unable to listen to the live broadcast, an audio replay of the conference call will be available on the UL Solutions website for 30 days.

Overjet Launches the Next Evolution of Insurance Intelligence Platform

Retrieved on: 
Martedì, Maggio 7, 2024

BOSTON, May 7, 2024 /PRNewswire/ -- Overjet, the world-leader in dental AI, today introduced the next evolution of its Insurance Intelligence Platform. The AI-powered platform now streamlines clinical workflows from end to end — so dental insurers can operate more efficiently while providing exceptional care to their members. With Overjet, insurers can approve claims an average of five times faster.

Key Points: 
  • Overjet added major enhancements to its Insurance Intelligence Platform, including an AI-powered marketplace for dental insurance services.
  • BOSTON, May 7, 2024 /PRNewswire/ -- Overjet , the world-leader in dental AI, today introduced the next evolution of its Insurance Intelligence Platform.
  • Over the last few years, Overjet transformed this process, called utilization review, by using artificial intelligence to automatically approve claims that meet insurers' guidelines.
  • Now, the Insurance Intelligence Platform can accelerate decisions on all claims, including those that require dental consultants to review.

Augmedix to Participate in Upcoming Investor Conferences in May and June 2024

Retrieved on: 
Venerdì, Maggio 3, 2024

SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced that its management team will participate in the following four investor conferences in May and June 2024.

Key Points: 
  • SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced that its management team will participate in the following four investor conferences in May and June 2024.
  • RBC Capital Markets Global Healthcare Conference (New York): Management will participate in a fireside chat on May 15 at 10:30 a.m.
  • B. Riley Annual Institutional Investor Conference (Beverly Hills, CA): Management will participate in a fireside chat on May 22 at 9:00 a.m. PT, and be available for 1x1 investor meetings.
  • William Blair Annual Growth Stock Conference (Chicago): Management will participate in a fireside chat on June 5 at 8:40 a.m. CDT, and be available for 1x1 investor meetings.

$15 Million SuperPAC "Battleground California" Targets Eight Congressional Districts to Take Back the House

Retrieved on: 
Mercoledì, Maggio 1, 2024

OAKLAND, Calif., May 1, 2024 /PRNewswire/ -- Today, Battleground California has become California's only independent expenditure coalition aimed at winning eight competitive congressional races that will securely position Democrats to take back the House from two more years of Republican control. Chaired by California Donor Table (CDT) and joined by Courage California, Communities for a New California, Planned Parenthood Affiliates of California VOTES, National Union of Healthcare Workers, Inland Empire United, CHIRLA Action Fund, Way to Win, the Working Families Party, and Movement Voter Project, the SuperPAC will invest $15 million targeting races where Latino, AAPI, and Black voters will be the margin of difference towards a Democratic-controlled Congress.

Key Points: 
  • Contrary to other battleground states, California lacks a long-term funding apparatus for progressive groups to coordinate efforts in critical congressional races.
  • Battleground California is designed to be a multi-cycle partnership, providing critical infrastructure for California's political future in federal elections.
  • Due to the integrity of California's fair redistricting process and the size of its population, the state holds the country's largest number of competitive districts.
  • CDT has a long and successful track record funding organizations engaging people of color to vote for Democratic candidates.